Trials / Completed
CompletedNCT02331992
Positive Airway Pressure Program
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Fisher and Paykel Healthcare · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Obstructive Sleep Apnea (OSA) is a common sleep disordered breathing condition effecting around 2-4% of the middle aged population and is characterized by periodic collapse of the upper airway during sleep. Continuous Positive Airway Pressure (CPAP) is the primary treatment for patients with OSA. Despite the effectiveness of CPAP in abolishing upper airway obstruction, acceptance of and adherence with therapy has been sub-optimal. Over the past decade, considerable research has focused on determining the factors responsible for poor CPAP adherence. Two key areas have been identified: patient-reported symptoms, including mask discomfort, pressure intolerance and nasal symptoms and the importance of patient education and support. In addition we know that the patient experience during the crucial first days and weeks of their journey predicts longer term adherence. This study investigates the ability of an automated program that assists patients towards continuous positive airway pressure (CPAP) therapy adherence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Adherence program | Participants will receive supportive messages while enrolled in the program. |
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2015-07-01
- Completion
- 2015-09-01
- First posted
- 2015-01-06
- Last updated
- 2018-10-29
- Results posted
- 2018-10-29
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02331992. Inclusion in this directory is not an endorsement.